Trial intelligence / Profile preview

Rescue progesterone supplementation in frozen embryo transfer

NCT05555121Phase 2Suspended

Sponsor
clinique ovo
Start
Dec 2022
Primary completion
Apr 2028
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of progesterone in infertility (2 arms), sponsored by clinique ovo. Primary endpoint: Ongoing pregnancy rate at 8 weeks. Started Dec 2022; status: suspended.

02

Drugs

progesterone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT05555121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05555121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call